Most employers have little idea what the pharmacy benefit managers they hire do with the money they exchange for the ...

Perioperative chemotherapy may be underused in patients with stage II-III esophageal cancer, according to researchers.

Five-fraction SBRT is “a robust and viable alternative” to conventionally or moderately fractionated radiotherapy for prostate cancer, researchers say.

Updated results from the CheckMate 274 trial support the use of adjuvant nivolumab as standard care for high-risk muscle-invasive urothelial carcinoma, according to researchers.

Gilead has made the decision to withdraw the accelerated approval of Trodelvy (sacituzumab govitecan) for advanced urothelial cancer in the United States.

An analysis of AYA cancer survivors in the US revealed “a substantial population of aging, long-term cancer survivors,” according to researchers.

The FDA has approved Vyloy (zolbetuximab-clzb) in combination with chemotherapy to treat advanced gastric or GEJ cancer.

The policy of billing for patient portal messages changes patient expectations and can impact the patient-physician ...

Vot-ER is an initiative that allows health care institutions to host nonpartisan conversations with patients about voting and direct them to websites where patients can check their registration, ...

Martin and colleagues’ latest study, published in June 2024 in JAMA Health Forum, finds that the Vot-ER project reaches a younger and more racially and ethnically diverse population, groups that are ...

Redispensing unused oral cancer drugs can have a beneficial impact on climate change, ecosystems, and human health, a study suggests.

Nurses were more likely than other health care workers to favor using AI-generated responses to patient portal messages.